These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31543462)
1. Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes. Béliveau F; Tarkar A; Dion SP; Désilets A; Ghinet MG; Boudreault PL; St-Georges C; Marsault É; Paone D; Collins J; Macphee CH; Campobasso N; Groy A; Cottom J; Ouellette M; Pope AJ; Leduc R Cell Chem Biol; 2019 Nov; 26(11):1559-1572.e9. PubMed ID: 31543462 [TBL] [Abstract][Full Text] [Related]
2. Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality. Béliveau F; Brulé C; Désilets A; Zimmerman B; Laporte SA; Lavoie CL; Leduc R J Biol Chem; 2011 Aug; 286(33):29035-29043. PubMed ID: 21724843 [TBL] [Abstract][Full Text] [Related]
3. Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway. Wahedi M; Wortham AM; Kleven MD; Zhao N; Jue S; Enns CA; Zhang AS J Biol Chem; 2017 Nov; 292(44):18354-18371. PubMed ID: 28924039 [TBL] [Abstract][Full Text] [Related]
4. Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis. Gnana-Prakasam JP; Baldowski RB; Ananth S; Martin PM; Smith SB; Ganapathy V Mol Vis; 2014; 20():561-74. PubMed ID: 24791141 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Finberg KE; Whittlesey RL; Fleming MD; Andrews NC Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349 [TBL] [Abstract][Full Text] [Related]
6. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. Lakhal S; Schödel J; Townsend AR; Pugh CW; Ratcliffe PJ; Mole DR J Biol Chem; 2011 Feb; 286(6):4090-7. PubMed ID: 20966077 [TBL] [Abstract][Full Text] [Related]
7. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966 [TBL] [Abstract][Full Text] [Related]
8. Identification of TMPRSS6 cleavage sites of hemojuvelin. Rausa M; Ghitti M; Pagani A; Nai A; Campanella A; Musco G; Camaschella C; Silvestri L J Cell Mol Med; 2015 Apr; 19(4):879-88. PubMed ID: 25704252 [TBL] [Abstract][Full Text] [Related]
9. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Truksa J; Gelbart T; Peng H; Beutler E; Beutler B; Lee P Br J Haematol; 2009 Nov; 147(4):571-81. PubMed ID: 19751239 [TBL] [Abstract][Full Text] [Related]
10. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload? Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887 [TBL] [Abstract][Full Text] [Related]
11. Low intracellular iron increases the stability of matriptase-2. Zhao N; Nizzi CP; Anderson SA; Wang J; Ueno A; Tsukamoto H; Eisenstein RS; Enns CA; Zhang AS J Biol Chem; 2015 Feb; 290(7):4432-46. PubMed ID: 25550162 [TBL] [Abstract][Full Text] [Related]
12. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in Krijt J; Frýdlová J; Gurieva I; Přikryl P; Báječný M; Steinbicker AU; Vokurka M; Truksa J Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800732 [TBL] [Abstract][Full Text] [Related]
13. Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease. Schaefer B; Haschka D; Finkenstedt A; Petersen BS; Theurl I; Henninger B; Janecke AR; Wang CY; Lin HY; Veits L; Vogel W; Weiss G; Franke A; Zoller H Hum Mol Genet; 2015 Nov; 24(21):6254-63. PubMed ID: 26310624 [TBL] [Abstract][Full Text] [Related]
14. A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates Pettinato M; Aghajan M; Guo S; Bavuso Volpe L; Carleo R; Nai A; Pagani A; Altamura S; Silvestri L Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G310-G317. PubMed ID: 38252872 [TBL] [Abstract][Full Text] [Related]
15. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2. Damalanka VC; Janetka JW Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556 [TBL] [Abstract][Full Text] [Related]
16. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Lenoir A; Deschemin JC; Kautz L; Ramsay AJ; Roth MP; Lopez-Otin C; Vaulont S; Nicolas G Blood; 2011 Jan; 117(2):647-50. PubMed ID: 20940420 [TBL] [Abstract][Full Text] [Related]
17. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model. Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of matriptase-2 mutations and domains: insights into the molecular basis of iron-refractory iron deficiency anemia. McDonald CJ; Ostini L; Bennett N; Subramaniam N; Hooper J; Velasco G; Wallace DF; Subramaniam VN Am J Physiol Cell Physiol; 2015 Apr; 308(7):C539-47. PubMed ID: 25588876 [TBL] [Abstract][Full Text] [Related]
19. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin. Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte neogenin is required for hemojuvelin-mediated hepcidin expression and iron homeostasis in mice. Enns CA; Jue S; Zhang AS Blood; 2021 Aug; 138(6):486-499. PubMed ID: 33824974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]